Daniel J. Mccarty

Daniel J. Mccarty's AcademicInfluence.com Rankings

Daniel J. Mccarty

Philosophy

#3740

World Rank

#5992

Historical Rank

Logic

#1369

World Rank

#2106

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Daniel J. Mccarty's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Daniel J. Mccarty Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel J. Mccarty's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preliminary criteria for the classification of the acute arthritis of primary gout. (1977) (1387)
Simple method for measurement of lower extremity muscle strength. (1985) (761)
The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates. (2002) (509)
The Significance of Calcium Phosphate Crystals in the Synovial Fluid of Arthritic Patients: The Pseudogout Syndrome: I. Clinical Aspects (1962) (503)
Incidence of systemic lupus erythematosus. Race and gender differences. (1995) (432)
The prevalence of and factors associated with diabetic retinopathy in the Australian population. (2003) (431)
Identification of urate crystals in gouty synovial fluid. (1961) (422)
The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. (1997) (322)
Geographic variation of inflammatory bowel disease within the United States. (1991) (310)
The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. (1976) (284)
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. I. Clinical aspects. (1981) (284)
Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. (1971) (271)
Capture-recapture and multiple-record systems estimation II: Applications in human diseases. International Working Group for Disease Monitoring and Forecasting. (1995) (264)
The reflex sympathetic dystrophy syndrome. A comprehensive analysis using fine-detail radiography, photon absorptiometry, and bone and joint scintigraphy. (1975) (264)
The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. (1962) (262)
Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. (1985) (250)
ACUTE ARTHRITIS IN MAN AND DOG AFTER INTRASYNOVIAL INJECTION OF SODIUM URATE CRYSTALS (1962) (238)
Ascertainment corrected rates: applications of capture-recapture methods. (1993) (196)
Calcium pyrophosphate dihydrate crystal deposition disease--1975. (1976) (194)
Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. (1992) (192)
STUDIES ON THE PATHOGENESIS OF RHEUMATOID JOINT INFLAMMATION. I. THE "R.A. CELL" AND A WORKING HYPOTHESIS. (1965) (189)
Capture-recapture and multiple-record systems estimation I: History and theoretical development ( Review ) (1995) (179)
Prevalence and associations of epiretinal membranes in the visual impairment project. (2005) (178)
The reflex sympathetic dystrophy syndrome. II. Roentgenographic and scintigraphic evidence of bilaterality and of periarticular accentuation. (1976) (174)
Studies on pathological calcifications in human cartilage. I. Prevalence and types of crystal deposits in the menisci of two hundred fifteen cadavera. (1966) (172)
Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. (1966) (169)
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. II. Synovial fluid studies. (1981) (151)
CRYSTAL-INDUCED INFLAMMATION IN CANINE JOINTS (1966) (145)
Release of platelet constituents by monosodium urate crystals. (1977) (135)
Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. (1986) (131)
Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. (1984) (129)
Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. (1991) (128)
Recurrent acute inflammation associated with focal apatite crystal deposition. (1966) (126)
Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. (1999) (121)
Release of collagenase, neutral protease, and prostaglandins from cultured mammalian synovial cells by hydroxyapatite and calcium pyrophosphate dihydrate crystals. (1981) (121)
INFLAMMATORY REACTION AFTER INTRASYNOVIAL INJECTION OF MICROCRYSTALLINE ADRENOCORTICOSTEROID ESTERS. (1964) (109)
Gout without hyperuricemia. (1994) (106)
Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. (1982) (104)
Diabetes care in an Australian population: frequency of screening examinations for eye and foot complications of diabetes. (2004) (101)
Identification of hydroxyapatite crystals in synovial fluid. (1979) (99)
Crystal populations in human synovial fluid. Identification of apatite, octacalcium phosphate, and tricalcium phosphate. (1983) (98)
Remitting, seronegative, symmetrical synovitis with pitting edema--13 additional cases. (1990) (97)
Mitogenesis induced by calcium-containing crystals. Role of intracellular dissolution. (1985) (95)
Compensated polarized light microscopy. Identification of crystals in synovial fluids from gout and pseudogout. (1968) (94)
Running Elevates Plasma β-Endorphin Immunoreactivity and ACTH in Untrained Human Subjects (1981) (92)
Type 2 diabetes worldwide according to the new classification and criteria. (2000) (90)
DIFFERENTIAL MEMBRANOLYTIC EFFECTS OF MICROCRYSTALLINE SODIUM URATE AND CALCIUM PYROPHOSPHATE DIHYDRATE (1971) (89)
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, ad neutral protease with rotator cuff defects. III. Morphologic and biochemical studies of an excised synovium showing chondromatosis. (1981) (88)
Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. (1972) (85)
Epidemiology of systemic lupus erythematosus in rural Wisconsin (2005) (84)
Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients. (1971) (84)
Tendon ruptures in patients with systemic lupus erythematosus treated with corticosteroids. (1974) (83)
Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. (1986) (82)
Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease. (2003) (81)
Synovial origins of Rice bodies in joint fluid. (1980) (80)
Counting birds, bees, and NCDs (1992) (77)
Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. (1975) (75)
Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. (2006) (72)
Crystal shedding and acute pseudogout. An hypothesis based on a therapeutic failure. (1976) (72)
Use of an Electronic Medical Record for the Identification of Research Subjects with Diabetes Mellitus (2007) (71)
Diseases associated with calcium pyrophosphate dihydrate crystal deposition. (1974) (71)
Crystals and arthritis. (1994) (66)
Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. (1981) (63)
Five‐year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project (2003) (60)
Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. (1985) (60)
Rheumatoid nodulosis an unusual variant of rheumatoid disease (1975) (57)
Why are today's medical students choosing high-technology specialties over internal medicine? (1987) (57)
Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome. (1988) (56)
Epidemiology of hospitalization for achalasia in the United States (1993) (56)
Milwaukee Shoulder syndrome: eleven additional cases with involvement of the knee in seven (basic calcium phosphate crystal deposition disease). (1984) (55)
Milwaukee shoulder syndrome. Fifteen additional cases and a description of contributing factors. (1990) (55)
PHAGOCYTOSIS OF URATE CRYSTALS IN GOUTY SYNOVIAL FLUID (1962) (54)
Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition. (1995) (54)
Association of constipation with neurologic diseases (1992) (53)
Suppress rheumatoid inflammation early and leave the pyramid to the Egyptians. (1990) (52)
Protein binding to monosodium urate monohydrate, calcium pyrophosphate dihydrate, and silicon dioxide crystals. I. Physical characteristics. (1977) (52)
Preliminary findings from an evaluation of the USDA Fresh Fruit and Vegetable Program in Wisconsin schools. (2008) (52)
Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and silica crystals: relationship to the pathogenesis of crystal-induced inflammation. (1976) (52)
Crystal induced inflammation in canine joints. 3. Evidence against bradykinin as a mediator of inflammation. (1966) (52)
Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia. (1973) (51)
Crystal-induced arthritis. (1969) (50)
Clearance of calcium pyrophosphate dihydrate crystals in vivo. I. Studies using 169Yb labeled triclinic crystals. (1979) (50)
Crystals, joints, and consternation. (1983) (48)
Calcium pyrophosphate dihydrate crystal deposition in neuropathic joints. Four cases of polyarticular involvement. (1973) (48)
Phagocytosis of Hydroxyapatite or Calcium Pyrophosphate Dihydrate Crystals by Rabbit Articular Chondrocytes Stimulates Release of Collagenase, Neutral Protease, and Prostaglandins E2 and F2α (1983) (48)
CRYSTAL-INDUCED INFLAMMATION IN CANINE JOINTS (1966) (48)
Monitoring the incidence of myocardial infarctions: applications of capture-mark-recapture technology. (1992) (48)
Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria. (1977) (47)
Cartilage Nucleoside Triphosphate (NTP) Pyrophosphohydrolase (1984) (46)
Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease. (1979) (45)
Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. (2006) (45)
Erythrocyte neutral inorganic pyrophosphatase in pseudogout. (1972) (44)
Crystal-induced inflammation of the joints. (1970) (44)
The arthritis of viral hepatitis. (1971) (43)
Histopathological and ultrastructural studies of synovium in Milwaukee shoulder syndrome--a basic calcium phosphate crystal arthropathy. (1984) (41)
A twenty-pound dolorimeter for quantification of articular tenderness. (1968) (41)
MULTIPLE MYELOMA WITH PARAMYLOIDOSIS PRESENTING AS RHEUMATOID DISEASE. (1964) (41)
Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. (1992) (40)
Treatment of pain due to fibromyalgia with topical capsaicin: A pilot study (1994) (40)
The inflammatory reaction to microcrystalline sodium urate. (1965) (40)
Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide. (1995) (39)
Establishment of accurate incidence rates for head and spinal cord injuries in developing and developed countries: a capture-recapture approach. (1993) (39)
Identification of inorganic pyrophosphate in human platelets and its release on stimulation with thrombin. (1973) (39)
The importance of incidence registries for connective tissue diseases. (1992) (39)
A historical note: Leeuwenhoek's description of crystals from a gouty tophus. (1970) (38)
Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease. (1986) (38)
Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult‐onset diabetes mellitus (1998) (38)
Suppressive effects of indomethacin on crystal-induced inflammation in canine joints and on neutrophilic motility in vitro. (1967) (37)
Altruism, Professional Decorum, and Greed: Perspectives on Physician Compensation (2015) (37)
Synovianalysis: an aid in arthritis diagnosis. (1961) (37)
Retrosomatic clefts: computed tomographic appearance. (1983) (36)
Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. (1996) (35)
Crystal-induced inflammation; syndromes of gout and pseudogout. (1963) (35)
A comparison of the duration of local anti-inflammatory effect of several adrenocorticosteroid esters--a bioassay technique. (1963) (35)
Molecular orientation of immunoglobulin G adsorbed to microcrystalline monosodium urate monohydrate. (1980) (35)
Identification of collagen subtypes in synovial fluid sediments from arthritic patients. (1980) (35)
Risk factors for postvitrectomy fibrin formation. (1990) (34)
Cartilage nucleoside triphosphate pyrophosphohydrolase. II. Role in extracellular pyrophosphate generation and nucleotide metabolism. (1985) (34)
Intraarticular corticosteroids possibly leading to local osteonecrosis and marrow fat induced synovitis. (1991) (34)
99m-technetium scintiphotography in arthritis. I. Technic and interpretation. (1970) (34)
Mitogenic activity of hydroxyapatite: Requirement for somatomedin C (1986) (34)
Specificity of a porcine 127-kd nucleotide pyrophosphohydrolase for articular tissues. (1996) (33)
THE PENDULUM OF PROGRESS IN GOUT: FROM CRYSTALS TO HYPERURICEMIA AND BACK. (1964) (32)
Combination drug therapy of seropositive rheumatoid arthritis. (1995) (32)
Enzymatic release of microspheroids containing hydroxyapatite crystals from synovium and of calcium pyrophosphate dihydrate crystals from cartilage. (1982) (32)
Significance of xenon-133 clearance rate from canine and human joints. (1972) (31)
Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout. (1974) (31)
99m-technetium scintiphotography in arthritis. II. Its nonspecificity and clinical and roentgenographic correlations in rheumatoid arthritis. (1970) (31)
The epidemic of NIDDM in Asian and Pacific Island populations: prevalence and risk factors. (1997) (31)
Inorganic pyrophosphate pool size and turnover rate in arthritic joints. (1975) (31)
ORIGIN AND SIGNIFICANCE OF RICE BODIES IN SYNOVIAL FLUID (1982) (30)
ARTHRITIS ROUNDS. (4). ASEPTIC NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. REPORT OF A CASE INVOLVING SIX JOINTS. (1964) (30)
Quantification of human plasma inorganic pyrophosphate (1979) (30)
"STUDIES ON THE NATURE OF GOUTY TOPHI" BY MAX FREUDWEILER, 1899. (AN INFLAMMATORY RESPONSE TO INJECTED SODIUM URATE, 1899). AN ABRIDGED TRANSLATION, WITH COMMENTS. (1964) (29)
Osteonecrosis, fractures, and protrusio acetabuli secondary to x-irradiation therapy for prostatic carcinoma. (1987) (29)
Pacific Island Populations (2002) (29)
Molecular cloning and expression of a porcine chondrocyte nucleotide pyrophosphohydrolase. (1997) (28)
Cultured human monocytes and fibroblasts solubilize calcium phosphate crystals (1984) (28)
Prostaglandin (PG) E2 generation by cultured canine synovial fibroblasts exposed to microcrystals containing calcium. (1985) (28)
Exercise and the endogenous opioids. (1981) (28)
Adenosine triphosphate levels in human plasma. (1996) (28)
Randomized trial on the treatment of oedematous acute otitis externa using ear wicks or ribbon gauze: clinical outcome and cost (2002) (27)
A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. (1995) (27)
Cultured canine synovial cells solubilize 45Ca-labeled hydroxyapatite crystals. (1984) (27)
Aplastic Anemia Secondary to Gold-Salt Therapy: Report of Fatal Case and a Review of Literature (1962) (27)
An overview of cellular and molecular mechanisms in cyrstal-induced inflammation. (1975) (27)
In vivo effects of fluoroquinolones on rabbit corneas (2003) (26)
The efficacy of fine-detail radiography in the evaluation of patients with rheumatoid arthritis. (1974) (26)
Survey of dry eye symptoms in Australian pilots (2000) (26)
Crystal deposition joint disease. (1974) (25)
Milwaukee shoulder syndrome. (1991) (25)
On the crystal deposition diseases. (1970) (24)
CRYSTAL DEPOSITION DISEASES: SODIUM URATE (GOUT) AND CALCIUM PYROPHOSPHATE (CHONDROCALCINOSIS, PSEUDOGOUT). (1965) (24)
Identification of collagen in synovial fluid. (1969) (24)
Health characteristics of inland waterway merchant marine captains and pilots. (2012) (23)
An experimental model of acute inflammation in man. (1966) (23)
Clearance of calcium pyrophosphate dihydrate crystals in vivo. III. Effects of synovial hemosiderosis. (1981) (22)
Treating intractable rheumatoid arthritis. (1981) (22)
Mechanisms of the crystal deposition diseases--gout and pseudogout. (1973) (22)
Hemorrhagic rupture of the shoulder. (1994) (22)
A rapid method for evaluating the structure and function of the rheumatoid hand. (1971) (21)
Parental History of Diabetes in an Insulin‐treated Diabetes Registry (1997) (20)
Radiographic changes in the hands following childhood frostbite injury (1980) (20)
Arthritis and HB Ag-positive hepatitis. (1973) (20)
Selected aspects of synovial membrane physiology. (1974) (19)
A comparative study of roentgenographic techniques for detection of calcium pyrophosphate dihydrate deposits (pseudogout) in human cartilage. (1967) (19)
Rheumatoid factors in the serum of gouty patients. (1977) (19)
Arthritis associated with calcium oxalate crystals in an anephric patient treated with peritoneal dialysis. (1988) (18)
The 1984 Tasmanian insulin treated diabetes mellitus prevalence cohort: an eight and a half year mortality follow-up investigation. (1995) (18)
Arthritis associated with crystals containing calcium. (1986) (18)
Mechanisms of connective tissue damage by crystals containing calcium. (1988) (18)
Identification of a nucleotide pyrophosphohydrolase from articular tissues in human serum. (1996) (17)
Crystal identification in human synovial fluids. Methods and interpretation. (1988) (17)
A comparison of cardiovascular disease risk factors in farm and non-farm residents: the Wisconsin Rural Women's Health Study. (2002) (17)
Basal urinary pyrophosphate excretion in pseudogout. (1969) (17)
Nucleotide pyrophosphohydrolase in human synovial fluid. (1997) (16)
Polymyalgia rheumatica begins at 40. (1979) (16)
Arthritis after frostbite injury in children. (1979) (16)
Pseudogout in acute neuropathic arthropathy. A clue to pathogenesis? (1974) (16)
Hereditary chondrocalcinosis in an Ashkenazi Jewish family. (1990) (16)
Serologic studies in a family with heterozygous C2 deficiency. (1981) (16)
A study of distal interphalangeal joint tenderness in rheumatoid arthritis (1966) (15)
Variations in Site and Levels of Expression of Chondrocyte Nucleotide Pyrophosphohydrolase with Aging (2001) (15)
Periarthritis associated with basic calcium phosphate crystal deposition and low levels of serum alkaline phosphatase--report of three cases from one family. (1988) (15)
CLearance of calcium pyrophosphate dihydrate crystals in vivo. II. Studies using triclinic crystals doubly labeled with 45Ca and 85Sr. (1979) (15)
Birth weight and systemic lupus erythematosus (2005) (14)
Surveillance of serious recreational injuries: a capture-recapture approach. (1993) (14)
Hemarthrosis complicating anticoagulant therapy. Report of three cases. (1966) (14)
Robert Adams' rheumatic arthritis of the shoulder: "Milwaukee shoulder" revisited. (1989) (14)
Arthropathies associated with calcium-containing crystals. (1986) (14)
The Physiology of the Normal Synovium (1980) (13)
Urate crystals, inflammation, and colchicine. (2008) (13)
Selected data on primary gout. (1978) (13)
"Milwaukee shoulder" syndrome: Microspherules containing hydroxyapatite, active collagenase and neutral protease in patients with rotator cuff defects and glenohumeral osteoarthritis (1981) (13)
Hypertrophic osteoarthropathy associated with cyanotic congenital heart disease. (1967) (13)
Pathogenesis and treatment of the acute attack of gout. (1970) (13)
Geographic distribution of consultant rheumatologists in the United States--1975. (1976) (13)
Complete reversal of rheumatoid nodulosis. (1991) (13)
The isohemagglutinin partition in rheumatoid arthritis. (1961) (12)
Gold induced aplastic anemia. Complete response to corticosteroids, plasmapheresis, and N-acetylcysteine infusion. (1985) (12)
Idiopathic Charcot joint of the elbow. (1978) (12)
Cartilage nucleoside triphosphate (NTP) pyrophosphohydrolase. I. Identification as an ecto-enzyme. (1984) (11)
RS3PE syndrome: no evidence for retroviruses. (1994) (11)
Identification of Calcium Hydrogen Phosphate Dihydrate Crystals in Human Fibrocartilage (1964) (11)
The Gouty Toe-A Multifactorial Condition (1977) (11)
Aspirin and the treatment of rheumatoid arthritis. (1989) (11)
The "R.A. cell", "ragocyte", or "inclusion body cell". (1965) (11)
Suppression of active collagenase from calcified lapine synovium by Arteparon. (1987) (11)
Hypertrophic osteoarthropathy with arthritis and synovial calcification in a patient with alcoholic cirrhosis. (1969) (11)
Calcium pyrophosphate dihydrate crystal deposition disease. (1993) (11)
Clinical outcomes following laser photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital (2003) (10)
Diagnosis: the scale of the problem and future risks (1999) (10)
Evidence that a 550,000-dalton cartilage matrix glycoprotein is a chondrocyte membrane-associated protein closely related to ceruloplasmin. (1993) (10)
Recurring myxomatous cutaneous cyst. (1954) (10)
Serum nucleotide pyrophosphohydrolase activity; elevated levels in osteoarthritis, calcium pyrophosphate crystal deposition disease, scleroderma, and fibromyalgia. (1998) (10)
Endocytosis precedes dissolution of basic calcium phosphate crystals by murine macrophages (1986) (9)
Joint Sepsis: A Chance for Cure (1982) (9)
Erysipelothrix Endocarditis: Report on a Septicemic Form of the Erysipeloid of Rosenbach (1960) (9)
Synovial hemangioma of the knee. (1969) (9)
Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. (1991) (9)
Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination. (1993) (9)
THE ROENTGENOGRAPHIC ASPECTS OF PSEUDOGOUT (ARTICULAR CHONDROCALCINOSIS). AN ANALYSIS OF 20 CASES. (1963) (9)
Disease monitoring (1993) (9)
Diagnosis of gouty arthritis. 18 months' experience with a pathognomonic test. (1963) (8)
Inorganic pyrophosphate levels in blood platelets from normal donors and patients with calcium pyrophosphate dihydrate crystal deposition disease. (1983) (8)
Tubular structures in endothelium in palindromic rheumatism. (1972) (8)
Transient hypothermia after corticosteroid treatment of subacute cutaneous lupus erythematosus. (1984) (8)
Variation in plasma and urinary inorganic phosphate and pyrophosphate in normal subjects and in patients with acromegaly or osteoarthritis. (1980) (8)
Intrasynovial corticosteroid therapy (1994) (8)
Spontaneous rupture of the knee joint in Reiter's syndrome. (1969) (8)
Adenocarcinoma of the lung associated with eosinophilia and hidebound skin. (1994) (8)
Pseudogout and pyrophosphate metabolism. (1980) (7)
Clinical significance of synovial fluid total hemolytic complement activity. (1980) (7)
Endocytosis is required for the mitogenic effect of basic calcium phosphate crystals in fibroblasts (1987) (7)
Identification of calcium pyrophosphate dihydrate crystals. (1992) (7)
Glucose intolerance in Wisconsin's Hmong population. (2005) (7)
Comparison of polymyalgia rheumatica and remitting seronegative symmetrical synovitis with pitting edema syndrome: comment on the article by Salvarani et al. (1996) (7)
American rheumatology--the future of our guild. Antidisestablishmentarianism. (1980) (7)
Clearance of 85Sr-labeled calcium phosphate crystals from rabbit joints. (1984) (7)
Coexistent gout and rheumatoid arthritis. (1981) (6)
Stimulation of inorganic pyrophosphate elaboration by cultured cartilage and chondrocytes. (1989) (6)
Delivery of photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital: comparisons with national clinical practice guidelines (2002) (6)
Cartilage inorganic pyrophosphate elaboration is independent of sulfated glycosaminoglycan synthesis. (1990) (6)
Protein binding to monosodium urate crystals and its effect on platelet degranulation. (1977) (6)
Generation of inorganic pyrophosphate from extracellular adenosine triphosphate by human serum and plasma. (1996) (6)
Management of insulin‐treated diabetes in Tasmania (1999) (5)
Differences in preventive screening rates in Wisconsin farm and non-farm resident women. (2003) (5)
Clinical aspects of basic calcium phosphate crystal deposition. (1988) (5)
Self‐reported diabetes and distribution of HbA1c in a population‐based sample in Victoria (1999) (4)
Measurement of arthritic disease disability. (1973) (4)
Short-Term Drug Control of Crystal-Induced Inflammation (1979) (4)
Precipitation and Deposition of Monosodium Urate Monohydrate Crystals in Tissues (1991) (4)
Intractable gouty arthritis. (1987) (4)
Quantification of human plasma inorganic pyrophosphate. II. Biologic variables. (1979) (4)
Calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis. (1985) (4)
Beyond Insulin-Dependent Diabetes Mellitus Registries: Capture-Recapture Approaches for Monitoring Incidence (1994) (4)
Biological Effects of Calcium-Containing Crystals on Synoviocytes (1985) (4)
Letters to the Editor Age-Standardization in Epidemiological Data (1994) (4)
CRYSTAL DEPOSITION DISEASES: GOUT AND PSEUDOGOUT. (1965) (3)
Calories from newspaper dessert recipes are associated with community obesity rates. (2007) (3)
Suppressive effects of indoxole in crystal-induced synovitis in man. (1967) (3)
ARTHRITIS AND ALLIED CONDITION : a textbook of rheumatology (2017) (3)
Tropical pyomyositis presenting as sciatica in Wicklow. (1997) (3)
Aspirin in the treatment of chronic inflammatory arthritis. (1987) (3)
Re: "Determination of lung cancer incidence in the elderly using Medicare claims data". (1994) (2)
The management of gout. (1979) (2)
THE DIFFERENTIAL DIAGNOSIS OF ARTHRITIS. (1964) (2)
Moraxella septic arthritis in an adult. (1995) (2)
ECTO-NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE ACTIVITY AND CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTAL DEPOSITION DISEASE: 231 (1985) (2)
Alphonsus of Ligouri. A patron for the handicapped. (1989) (2)
We need simple guidelines for reporting rates of rheumatic diseases. (1999) (2)
Treatment of Rheumatoid Arthritis-Reply (1983) (2)
Geographical distribution of consultant rheumatologists in the United States--1979. (1980) (1)
The American Rheumatism Association and the Arthritis Foundation: commentary on 14 years of a happy union. (1979) (1)
Heberden Oration , 1982 Crystals , joints , and consternation (1)
Geographic distribution of rheumatologists in Wisconsin, 1980. A guide to future need. (1981) (1)
Polysynovitis associated with acute Epstein-Barr virus infection. (1998) (1)
Intrasynovial therapy with adreno-corticosteroid esters. (1978) (1)
Perspective-syndrome of remitting seronegative symmetrical synovitis with pitting edema. (1995) (1)
Arthritis and rheumatism--the evolution of a journal. (1966) (1)
COMMENT ON: COMPARISON OF POLYMYALGIA RHEUMATICA AND REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA SYNDROME. AUTHORS' REPLY (1996) (1)
Equity in Physician Compensation: The Marshfield Experiment (2015) (1)
Hypertrophic osteoarthropathy after liver transplantation. (1989) (1)
An Overview of Rheumatic Disease Epidemiology (2008) (1)
Mitogenic effects of hydroxylapatite and calcium pyro phosphate di hydrate crystals on cultured synovial cells (1982) (0)
Results of controlled study of combination therapy with azathioprine and methotrexate in the treatment of rheumatoid arthritis revisited: comment on the article by Willkens et al. (1996) (0)
Arthritis and Calcium-Containing Crystals An Overview (1985) (0)
Crystal-Induced Arthropathies—Historical Aspects (2006) (0)
Calcium Pyrophosphate Dihydrate Crystal Deposition in Neuropathic Joints (2020) (0)
Pressure erosions: rheumatoid arthritis or calcium pyrophosphate dihydrate crystal deposition disease? (1986) (0)
Pathophysiology of Osteoarthritis (1992) (0)
Age at diagnosis of Type 1 diabetes and the prevalence of antiGAD in first degree relatives (1998) (0)
Barriers to Leisure-Time Physical Activity among Residents of a Rural Wisconsin Community: 1914 (2007) (0)
The Marshfield Youth Health Study: design, objectives and cohort characteristics. (2005) (0)
Valvular heart disease and systemic lupus erythematosus. (1997) (0)
The Management of Insulin-Treated Diabetes in Tasmania: Results from a Population-Based Study (1996) (0)
Hemorrhagic rupture of the shoulder. Author's reply (1995) (0)
Age-standardization in epidemiological data. (1994) (0)
Immune complex disease and gynecomastia. (1989) (0)
THE PATIENT ON LONG TERM ADRENOCORTICAL STEROID THERAPY. (1963) (0)
Multiple Myeloma witParamyloidosis PresentinAs Reumatoid Disease (1964) (0)
Possible role of bone marrow fat in the development of an inflammatory response to sickled erythrocytes: comment on the article by Mann and Schumacher. (1995) (0)
"The Informer": a remote emergency notification device. (1993) (0)
Book Review Archibald Garrod and the Individuality of Man By Alexander G. Bearn. 227 pp., illustrated. New York, Oxford University Press, 1993. $49.95. 0-19-262145-9 (1994) (0)
THE PATIENT ON LONG TERM ADRENOCORTICAL STEROID THERAPY (1964) (0)
Remitting Seronegative Symmetrical Synovitis With Pitting Edema-Reply (1986) (0)
2377 A Rare Case of Klebsiella Pneumoniae Liver Abscess With Subsequent Invasive Disease (2019) (0)
[abstract] RESULTS OF ALL PATIENTS HAVING A DIAGNOSIS OF DIABETIC FOOT ULCERS AT REDLANDS COMMUNITY HOSPITAL WOUND CARE DEPARTMENT FROM 1999-2002 (2003) (0)
The epidemiology of achalasia in the medicare population (1990) (0)
Polymyalgia rheumatica. A rheumatic disease of the elderly. (1967) (0)
Significance of collagen in synovial fluid from arthritic patients (1980) (0)
Prostaglandin (PG)E2generation bycultured canine synovial fibroblasts exposed tomicrocrystals containing calcium (1985) (0)
Book review: Advances of diabetes mellitus in East Asia edited by G. Mimura, W. Shu, K. Kida, K. Murakami. Elsevier Science, Amsterdam, 1997. No. of pages 288. Price US $184/50, hardback. ISBN 0‐444‐82664‐5 (1998) (0)
That Ode Feeling (1981) (0)
Continued Evolution of a Journal (1970) (0)
Best practices in product development: A case study of remote deposit capture (2009) (0)
[abstract] OUTCOME MEASURES OF ALL PATIENTS HAVING A DIAGNOSIS OF VENOUS STASIS ULCERS AT REDLANDS COMMUNITY HOSPITAL WOUND CARE DEPARTMENT FROM 1999-2002 (2003) (0)
Introducitn the new editor, Nathan J. Zvaifler, MD (1980) (0)
[abstract] WOUND CARE PATIENT ANALYSIS, REVIEWING 155 CONSECUTIVE PATIENTS DISCHARGED FROM OUTPATIENT TREATMENT (2002) (0)
Book Review Gout: The patrician malady By Roy Porter and G.S. Rousseau. 393 pp., illustrated. New Haven, Conn., Yale University Press, 1998. $35. 0-300-07386-0 (1999) (0)
Diagnostic criteria for diabetes: the relationship of retinopathy and microalbuminuria with glycaemia (2002) (0)
Mechanisms of Pathological Mineralization Group Report (1982) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel J. Mccarty?

Daniel J. Mccarty is affiliated with the following schools:

Medical College of Wisconsin